Elizabeth Arden (RDEN) Posts Q4 adj.-Loss of $1.57/Share

Elizabeth Arden (NASDAQ: RDEN) reported Q4 EPS of ($1.57), $0.92 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $175.5 million versus the consensus estimate of $188.7 million.

OUTLOOK

The Company currently expects the following for fiscal 2016 (on an adjusted basis):

• Net sales increases driven by the International business and the Elizabeth Arden brand;
• Gross margin expansion primarily due to better sales mix, improved commercial execution and improved cost structure;
• Flat overall selling, general and administrative expenses, with lower indirect overhead costs and targeted reinvestment in advertising to accelerate revenue growth; and
• Improved EBITDA margins from gross margin expansion and lower indirect overhead expenses.

For earnings history and earnings-related data on Elizabeth Arden (RDEN) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c